Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 61 (3) , 1040-1046
- https://doi.org/10.1046/j.1523-1755.2002.00199.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Betaine Supplementation and Plasma Homocysteine in Healthy VolunteersArchives of internal medicine (1960), 2000
- Effect of High Dose Folic Acid Therapy on Hyperhomocysteinemia in Hemodialysis PatientsJournal of the American Society of Nephrology, 2000
- Homocysteine and AtherothrombosisNew England Journal of Medicine, 1998
- No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients.Nephrology Dialysis Transplantation, 1998
- Kinetic basis of hyperhomocysteinemia in patients with chronic renal failureKidney International, 1997
- Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomesKidney International, 1997
- Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1997
- Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from The NHLBI Family Heart StudyAtherosclerosis, 1995
- Same-day batch measurement of glycine betaine, carnitine, and other betaines in biological materialAnalytical Biochemistry, 1992
- Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineNew England Journal of Medicine, 1983